Clinical trial
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release…
NCT00301236 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00301236 |
|---|---|
| Title | Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder |
| Official title | A 5-Week Treatment, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of the Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules Administered Once Daily in Pediatric Children With Attention-Deficit/Hyperactivity Disorder |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ADHD, ADD |
| Intervention type | Drug |
| Interventions | Dexmethylphenidate HCl extended-release capsules |
| Enrollment | 252 |
| Start date | Feb 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Mar 10, 2006 |
| Last update posted | Dec 21, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: